USEUROPEAFRICAASIA 中文双语Français
Home / Top News

Nation's healthcare shines in global spotlight

By David Ho in Hong Kong | China Daily | Updated: 2019-04-10 07:27

Vast market catches eye of drug and medical device makers

It was a significant moment for world healthcare when two global pharmaceutical companies looked to China as the first country for approval of a new drug - bypassing the United States and European nations.

In December, the National Medical Products Administration approved Roxadustat, a drug developed by AstraZeneca and FibroGen, as a new treatment for anemia caused by chronic kidney disease in patients dependent on dialysis.

Nation's healthcare shines in global spotlight

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US